IL151314A0 - Micelles, methods for their preparation and methods for delivery of micelles to patients - Google Patents

Micelles, methods for their preparation and methods for delivery of micelles to patients

Info

Publication number
IL151314A0
IL151314A0 IL15131401A IL15131401A IL151314A0 IL 151314 A0 IL151314 A0 IL 151314A0 IL 15131401 A IL15131401 A IL 15131401A IL 15131401 A IL15131401 A IL 15131401A IL 151314 A0 IL151314 A0 IL 151314A0
Authority
IL
Israel
Prior art keywords
micelles
methods
patients
delivery
preparation
Prior art date
Application number
IL15131401A
Other languages
English (en)
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of IL151314A0 publication Critical patent/IL151314A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL15131401A 2000-02-18 2001-02-20 Micelles, methods for their preparation and methods for delivery of micelles to patients IL151314A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18376800P 2000-02-18 2000-02-18
PCT/US2001/005297 WO2001060382A1 (en) 2000-02-18 2001-02-20 Micelles

Publications (1)

Publication Number Publication Date
IL151314A0 true IL151314A0 (en) 2003-04-10

Family

ID=22674206

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15131401A IL151314A0 (en) 2000-02-18 2001-02-20 Micelles, methods for their preparation and methods for delivery of micelles to patients
IL151314A IL151314A (en) 2000-02-18 2002-08-18 Cymbals, methods of preparation and programming and pharmaceutical preparations containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL151314A IL151314A (en) 2000-02-18 2002-08-18 Cymbals, methods of preparation and programming and pharmaceutical preparations containing them

Country Status (10)

Country Link
US (3) US6906042B2 (enExample)
EP (2) EP2452684B1 (enExample)
JP (2) JP4959085B2 (enExample)
KR (1) KR100841813B1 (enExample)
AU (2) AU2001238507C9 (enExample)
CA (1) CA2400371C (enExample)
ES (1) ES2664818T3 (enExample)
HK (1) HK1052872A1 (enExample)
IL (2) IL151314A0 (enExample)
WO (1) WO2001060382A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030130212A1 (en) * 1999-01-14 2003-07-10 Rossignol Daniel P. Administration of an anti-endotoxin drug by intravenous infusion
AU2001238507C9 (en) * 2000-02-18 2005-07-07 Eisai R&D Management Co., Ltd. Micelles
JP4366081B2 (ja) * 2001-05-22 2009-11-18 エーザイ・アール・アンド・ディー・マネジメント株式会社 高度に精製されたアンチエンドトキシン化合物
US7727974B2 (en) 2001-08-10 2010-06-01 Eisai R & D Management Co., Ltd. Methods of reducing the severity of mucositis
WO2003013440A2 (en) * 2001-08-10 2003-02-20 Eisai Co., Ltd. Treatment and prevention of heat shock protein-associated diseases and conditions
WO2003082303A1 (en) * 2002-03-29 2003-10-09 Wisconsin Alumni Research Foundation Polymeric micelle formulations of hydrophobic compounds and methods
WO2004034992A2 (en) * 2002-10-15 2004-04-29 Wisconsin Alumni Research Foundation Encapsulation and deaggregation of polyene antibiotics using poly(ethylene glycol)-phospholipid micelles
CA2536283A1 (en) * 2003-08-20 2005-03-03 Ajinomoto Co., Inc. Pharmaceutical preparations having an improved solubility
ATE446581T1 (de) * 2004-03-12 2009-11-15 Trinity College Dublin Magnetoresistives medium
WO2007026675A1 (ja) * 2005-08-31 2007-03-08 Eisai R & D Management Co., Ltd. リピッドａ類縁体の製造方法
US20070249572A1 (en) * 2005-12-20 2007-10-25 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
US20070178049A1 (en) * 2005-12-20 2007-08-02 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile
US20070197486A1 (en) * 2005-12-20 2007-08-23 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids
US20070160542A1 (en) * 2005-12-20 2007-07-12 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile
US20070185066A1 (en) * 2005-12-20 2007-08-09 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
JP2009526619A (ja) * 2006-02-15 2009-07-23 ティカ レーケメデル アーベー 質量減量を伴うコルチコステロイドの滅菌
BR112014024139A8 (pt) 2012-03-28 2018-01-16 Univ Maryland administração de eritoran ou sais farmaceuticamente aceitáveis do mesmo para tratar infecções de ortomixovírus
WO2018053073A1 (en) 2016-09-16 2018-03-22 Eisai R&D Management Co., Ltd. Method of use of eritoran as a tlr4 antagonist for treatment of ebola and marburg disease
BR112021010717A2 (pt) 2018-12-17 2021-08-31 Eisai R&D Management Co., Ltd. Formulação que compreende lipossomas
US11198831B2 (en) 2019-01-31 2021-12-14 Kvi Llc Lubricant for a device
WO2021207218A1 (en) 2020-04-06 2021-10-14 Eisai R&D Management Co., Ltd. Treatment of nidovirales infection with eritoran

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530113A (en) 1991-10-11 1996-06-25 Eisai Co., Ltd. Anti-endotoxin compounds
US6417172B1 (en) 1995-06-05 2002-07-09 Eisai Co., Ltd. Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs
US5681824A (en) 1995-06-05 1997-10-28 Eisai Co., Ltd. Substituted liposaccharides useful in the treatment and prevention of endotoxemia
AU7254396A (en) * 1995-09-29 1997-04-17 Eisai Research Institute Method for treating alcoholic liver disease
JP4326030B2 (ja) * 1996-07-03 2009-09-02 エーザイ・アール・アンド・ディー・マネジメント株式会社 リピッドａ類縁体含有注射用製剤及びその製造方法
US6235724B1 (en) * 1996-07-03 2001-05-22 Eisai Co., Ltd. Injections containing lipid a analogues and process for the preparation thereof
US6495532B1 (en) 1997-03-19 2002-12-17 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
JP2002501540A (ja) 1997-05-23 2002-01-15 エーザイ株式会社 製薬製剤を調製するための方法
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
EP1250141A4 (en) 2000-01-14 2007-05-16 Eisai Co Ltd Prevention and treatment of endotoxemia and related complications in the field of surgery
AU2001238507C9 (en) 2000-02-18 2005-07-07 Eisai R&D Management Co., Ltd. Micelles
US6861512B2 (en) 2000-03-01 2005-03-01 Eisai Co., Ltd. Separation of olefinic isomers
US20030105033A1 (en) 2000-06-09 2003-06-05 Rossignol Daniel P. Administration of an anti-endotoxin drug by bolus or intermittent intravenous infusion
JP4179881B2 (ja) 2000-12-06 2008-11-12 エーザイ株式会社 凍結乾燥ケークの抵抗を測定するためのシステム及び方法
WO2002089743A2 (en) 2001-05-09 2002-11-14 The Regents Of The University Of Michigan Use of compositions for treating rosacea
US7727974B2 (en) 2001-08-10 2010-06-01 Eisai R & D Management Co., Ltd. Methods of reducing the severity of mucositis
AU2004218358A1 (en) 2003-03-05 2004-09-16 Eisai R&D Management Co., Ltd. Compositions and methods for preventing and treating endotoxin-related diseases and conditions

Also Published As

Publication number Publication date
AU2001238507B2 (en) 2004-04-22
AU2001238507C1 (en) 2005-02-24
WO2001060382A1 (en) 2001-08-23
JP2012116860A (ja) 2012-06-21
EP2452684B1 (en) 2018-01-24
US6906042B2 (en) 2005-06-14
IL151314A (en) 2007-06-03
CA2400371A1 (en) 2001-08-23
HK1052872A1 (zh) 2003-10-03
US7989432B2 (en) 2011-08-02
EP1274443B1 (en) 2017-05-10
KR100841813B1 (ko) 2008-06-26
US20030216331A1 (en) 2003-11-20
KR20030011774A (ko) 2003-02-11
JP2003522797A (ja) 2003-07-29
AU2001238507C9 (en) 2005-07-07
US20050181039A1 (en) 2005-08-18
ES2664818T3 (es) 2018-04-23
EP2452684A3 (en) 2012-10-03
US7390793B2 (en) 2008-06-24
JP4959085B2 (ja) 2012-06-20
AU3850701A (en) 2001-08-27
EP2452684A2 (en) 2012-05-16
EP1274443A1 (en) 2003-01-15
US20090136564A1 (en) 2009-05-28
EP1274443A4 (en) 2008-12-31
CA2400371C (en) 2009-12-08

Similar Documents

Publication Publication Date Title
IL151314A0 (en) Micelles, methods for their preparation and methods for delivery of micelles to patients
HUP0300209A3 (en) Lipid nanocapsules, preparation method and use as medicine
IL156531A0 (en) Lipid nanoparticles, their preparation and pharmaceutical compositions containing them
AU2001240753A1 (en) Lipid nanocapsules, preparation method and use as medicine
HRP20040027A2 (en) 1-phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
HUP0300527A3 (en) Pyrrolopyrimidinone derivatives, process of preparation and use
HUP0301121A3 (en) Topical pharmaceutical formulations and methods of treatment
HUP0303078A3 (en) Cyclic peptidies process for their preparation pharmaceutical compositions containing them and their use
HUP0204229A3 (en) Compositions oral opioid formulations, compositions process for their preparation and their use
HUP0301685A3 (en) New aporphine esters and their use in therapy, process for their preparation and pharmaceutical compositions containing them
PL355844A1 (en) Novel pharmaceutical compositions of anti-tubrcular drugs and process for their preparation
IL153708A0 (en) Benzimidazole derivatives, preparation and therapeutic use thereof
HUP0301892A3 (en) Pharmaceutical compositions for treatment of sexual dysfunction and their preparation
HUP0400548A3 (en) Use of combinations of iop-reducing active inoredient for preparation of pharmaceutical compositions available for treatment glaucoma
EP1181022A4 (en) MEDICAL COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
HUP0302050A3 (en) Pharmaceutical form of administration for peptides, method for its production and use
HUP0400926A3 (en) Lipid lowering new biphenylcarboxamides, process for their preparation and pharmaceutical compositions containing them
TWI318974B (en) Acylaminothiazole derivatives, their preparation and their therapeutic use
IL156532A0 (en) Lipid microparticles, their preparation and pharmaceutical compositions containing them
IL149360A0 (en) Method and compositions for administering taxanes orally to human patients
HUP0303731A3 (en) Sulfonylguanidines and their use for preparation of pharmaceutical compositions
HUP0203627A3 (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical compositions comprising them
HUP0303977A3 (en) Procedure for the preparation of pure phosphatides and their use in the cosmetic, pharmaceutical nad alimentary fields
HUP0302310A3 (en) Novel formulations of alpha-2,4-disulfophenyl-n-tert-butylnitrone and process for their preparation
HUP0303597A3 (en) Diposable vaginal cannula for the simultaneous administration of drugs in different forms

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed